
Omar Eduardo Benavides Ayala
Fundación Hospital San Pedro, ColombiaTitle: Classic biphasic pulmonary blastoma in adults: an up-date review of a rare disease
Abstract
Pulmonary blastoma Pulmonary blastoma (BP) is a rare
lung cancer that accounts for a small fraction of primary lung tumors. There
are around 280 cases reported in adults older than 40 years old, with a few
cases reported in Latin América and the Caribbean. This tumor presents a
histological heterogeneity of malignancies mixed epithelial and mesenchymal. In
addition, cytokeratin and vimentin expression in the blastomatous component
that provides more support for a single origin. Molecularly, it has been associated
with mutations of p53 and ROS1 signaling pathways. The symptoms are
non-specific, with 40% of patients asymptomatic before diagnosis. The
diagnostic imaging may show signs of this disease, and a biopsy can be done
through bronchoscopy or thoracoscopy. Timely diagnosis is very important given
the poor prognosis of this disease. In focal lesions, a surgical approach is
preferred. However, complementary therapies remain controversial due to the
rarity of the disease. Researchers have investigated using radiotherapy cycles
specifically for tumors that cannot be surgically removed. The combination of
cyclophosphamide, vincristine, doxorubicin, and dactinomycin has been proven
effective in treating this cancer. The approach and dissemination of this type of
cases helps to visualize the approach and adequate treatment of this pathology
that, given its rarity, the lack of knowledge can have an impact on the
patient's prognosis.
Biography
To be updated